Video
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
A case of retinal detachment in tertiary syphilis
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Novel radiosurgical platform to treat a case of uveal melanoma
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
FDA issues Complete Response Letter to Aldeyra Therapeutics for resubmitted New Drug Application of reproxalap
Methylphenidate may impact corneal cells in children with ADHD
Part 4: Biggest innovations in ophthalmology in 50 years
Doctors warn TikTok & Instagram reels may be damaging eyes long-term